National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Dictionary of Cancer Terms
In EnglishEn español
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In EnglishEn español

recombinant adenovirus-p53 (ree-KOM-bih-nunt A-den-oh-VY-rus ...)

 A substance that has been studied in the treatment of some types of cancer. Recombinant adenovirus-p53 is a weakened adenovirus that carries the p53 gene into tumor cells, causing them to die. It is a type of gene therapy. Also called SCH-58500, ACN53, and rAd/p53.



Previous Definitions:rebeccamycin, rebeccamycin analog, Recentin, receptor, recombinant
Next Definitions:recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine, recombinant human interleukin-2, recombinant tissue plasminogen activator, recombinant vaccinia-CEA-MUC-1-TRICOM vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov